UTHealth Turner Syndrome Research Registry
Part of paid clinical trials in Houston, Texas.
- Sponsor
- The University of Texas Health Science Center, Houston
- Study ID
- NCT03185702
- Status
- Recruiting
Conditions
- Turner Syndrome
Eligibility Criteria
- Sex
- FEMALE
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Research genetic tests — GENETICDNA and tissue-based tests: karyotype, copy number variants, genome-wide association studies and induced pluripotent stem cells
Study Details
The investigators will conduct genetic comparisons between Turner Syndrome (TS) patients with and without Bicuspid Aortic Valve (BAV) to identify causative agents of BAV in people with TS. The investigators will correlate the patterns and prevalence of structural heart defects in TS women with emerging molecular data to identify patients who are at high risk for cardiovascular complications
Key Dates
- Start date
- Aug 28, 2015
- Status verified
- Nov 2023
- Primary completion
- Jan 1, 2030
- Completion
- Jan 1, 2035
Study Design
- Enrollment
- 200 participants (estimated)
Arms
- Arm: Patients with Turner SyndromeChromosomal diagnosis and typical features
- Arm: Unaffected controlsNormal females and unaffected family members
Primary Outcome Measure
Bicuspid aortic valve and thoracic aortic aneurysm [ Time Frame: 10 years ]
Central Contacts
- Siddharth Prakash, MD, PhD7135007003
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Texas Health Science Center Houston | Houston | Texas | 77030 | Jacqueline Jennings 713-500-6704 Siddharth Prakash, MD, PhD (SUB_INVESTIGATOR) Michelle Rivera-Davila, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Houston, TX
By research site
Related Studies
- Inspiring New Science In Guiding Healthcare in Turner Syndrome RegistryRecruiting · University of Colorado, Denver · Aurora, Colorado
- Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient DisordersPHASE3 · Recruiting · Ascendis Pharma A/S · Sacramento, California
- Natural History of Noncirrhotic Portal HypertensionRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland
- Parent and Infant Inter(X)Action Intervention (PIXI)Enrolling By Invitation · RTI International · Research Triangle Park, North Carolina